Thursday Feb 9 | Freshnews
Acorda Therapeutics to Present at Leerink Swann 2012 Global Healthcare Conference
Acorda Therapeutics, Inc. today announced that Ron Cohen, M.D., President & CEO, will present at the Leerink Swann 2012 Global Healthcare Conference on Thursday, February 16, 2012 at 4:00 pm ET at the Walfdorf=Astoria Hotel in New York, NY.
Watson, Acorda partner to introduce tizanidine hydrochloride capsules
Acorda Therapeutics, Inc. today announced that the Company has partnered with Watson Pharma, Inc., a subsidiary of Watson Pharmaceuticals, Inc.
Also on Topix